Whitepaper: Accelerating Gαq GPCR Drug Discovery with recognized and reliable tool
Cisbio Bioassays has developed a GPCR platform based on the company’s HTRF® technology to measure second messenger accumulation...
List view / Grid view
Cisbio Bioassays has developed a GPCR platform based on the company’s HTRF® technology to measure second messenger accumulation...
The study of biochemistry provides molecular insights into how the human population ages, how diseases commence and progress, how molecular changes relate to disease remission and relapse, and how humans respond to treatments...
Featured in this Omics In-depth Focus: The next revolution in stratified medicine-molecular phenotyping with metabolomics; Pharmacometabolomics as the key to personalised medicine...
Blanketed administration of drugs to all populations assumes that all patients respond similarly. Despite pharmaceutical companies’ efforts to develop drugs with large therapeutic windows, there are often and inevitably subpopulations of individuals who will either not respond to therapy or will respond with adverse effects...
12 May 2016 | By Victoria White, Digital Content Producer
Dr Andrei Goga of UC San Francisco has taken a multi-faceted approach to identifying new therapeutic targets in MYC-driven triple-negative breast cancers...
2 March 2016 | By Victoria White
Researchers looked at the metabolism of neurons lacking DJ1 and discovered that two key metabolic pathways are affected...